Indacaterol maleate clinical trials
A product of Indacaterol; its studies count on that page too.
How each study uses indacaterol maleate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 1 Jul 2011 · ARCAPTA NEOHALER · NDA 022383 (FDA, Drugs@FDA)
- European Union
- 29 Nov 2009 · Onbrez Breezhaler · EMEA/H/C/001114 (EMA; as indacaterol)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 2
Novartis (6) · Novartis Pharmaceuticals (5) · University of Milan (2) · Orion Corporation, Orion Pharma (1) · Mundipharma Research Limited (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Indacaterol
Studies
Open first, then newest update. How each study uses indacaterol maleate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Absorption of Indacaterol and Glycopyrronium From Ultibro BreezhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT04856098Written as Indacaterol maleate and glycopyrronium bromideHow we know
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedPhase 2Novartis PharmaceuticalsNCT03257995Written as Indacaterol maleateHow we know
- Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaCompletedPhase 1NovartisNCT00624702Written as Indacaterol maleateHow we know
- Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedPhase 4Novartis PharmaceuticalsNCT02202616Written as Glycopyrronium /Indacaterol maleateHow we know
- Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedPhase 4Novartis PharmaceuticalsNCT01985334Written as Indacaterol maleate and glycopyrronium bromideHow we know
- A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated EosinophilsTerminatedPhase 2/3Mundipharma Research LimitedNCT02693769Written as Indacaterol maleate / glycopyrronium bromide capsulesHow we know
- Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent AsthmaCompletedPhase 2/3NovartisNCT00403637Written as indacaterol maleateHow we know
- A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 DeviceCompletedPhase 2Novartis PharmaceuticalsNCT01484197Written as 75 µg indacaterol maleate (LB)How we know
- Closing Volume Interpretation and Bronchodilators EffectCompletedPhase 4University of MilanNCT01437748Written as Indacaterol maleateHow we know
- Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related DyspneaCompletedPhase 4University of MilanNCT01377051Written as Indacaterol maleateHow we know
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With AsthmaCompletedPhase 2Novartis PharmaceuticalsNCT00927901Written as Indacaterol maleate 400 μgHow we know
- Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With AsthmaCompletedPhase 2NovartisNCT00556673Written as indacaterol maleate/mometasone furoateHow we know
- Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate AsthmaCompletedPhase 2NovartisNCT00605306Written as indacaterol maleate / mometasone furoateHow we know
- Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent AsthmaCompletedPhase 2NovartisNCT00557440Written as indacaterol maleate / mometasone furoateHow we know
- Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2/3NovartisNCT00396604Written as indacaterol maleateHow we know
As the comparator · 1 — what is tested is compared with indacaterol maleate
Codes
What other systems call indacaterol maleate · ClinicalTrials.gg INT014488
- UNII (FDA) 2JEC1ITX7RINDACATEROL MALEATEConfirmed FDA, Wikidata
- RxNorm 1114325Confirmed FDA, Wikidata
- Wikidata Q27137018indacaterol maleateConfirmed FDA, Wikidata
- NCI Thesaurus C81640Indacaterol MaleateOne source FDA
- DrugBank DBSALT000101One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2JEC1ITX7R | INDACATEROL MALEATE | Confirmed FDA, Wikidata |
| RxNorm | 1114325 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27137018 | indacaterol maleate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C81640 | Indacaterol Maleate | One source FDA |
| DrugBank | DBSALT000101 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.